十年COPD患者可治疗的特征:关于其应用的经验教训
F L de Zwart1, M A Spruit2, A J van T Hul3
1Department of Pulmonary Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands; Department of Primary and Community Care, Radboudumc Research Institute for Medical Innovation, P.O. Box 9101tbox9101, 6500 HB Nijmegen, The Netherlands.
可治疗的特征 (TTs) 通过识别患者的特征来改善慢性阻塞性肺病 (COPD) 护理. 实施这种综合护理模式需要评估,个性化计划和专业间合作,以获得更好的结果.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 医疗保健管理的管理
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种普遍存在的呼吸道疾病,对患者产生重大影响.
- "可治疗特征" (TTs) 方法确定了患者的关键特征,以加强COPD管理.
- 转录症被分为肺部,肺外和行为领域,在患者中经常共存.
研究的目的:
- 开发和实施基于TT方法的COPD综合综合护理模式.
- 为提供关于提供综合性COPD护理的考虑和决策过程的见解.
主要方法:
- 利用TT模型,包括评估,个性化治疗计划和执行阶段.
- 专注于跨专业合作和案例管理,以执行计划.
- 描述了整合护理理念的设计和实施过程中遇到的过程,结果和挑战.
主要成果:
- 开发了一个综合性护理模型,整合了评估,治疗计划和执行.
- 该研究强调了在实践中实施这种综合护理模式的复杂性和挑战.
- 确定需要在肺部康复之外广泛应用,特别是在初级和二级护理环境中.
结论:
- 技术技术方法为个性化COPD护理提供了一个框架,但实施面临挑战.
- 综合护理模型对于管理具有多种特征的复杂COPD患者至关重要.
- 需要进一步努力,以促进在常规临床实践中广泛采用基于TT的综合护理.
更多相关视频
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
